AIM ImmunoTech Inc. (AIM)

AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $3.83 million. The enterprise value is $3.75 million.

Market Cap	3.83M
Enterprise Value	3.75M

Important Dates

The last earnings date was Tuesday, November 18, 2025, before market open.

Earnings Date	Nov 18, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 2.86 million shares outstanding. The number of shares has increased by 102.28% in one year.

Current Share Class	2.85M
Shares Outstanding	2.86M
Shares Change (YoY)	+102.28%
Shares Change (QoQ)	+175.71%
Owned by Insiders (%)	3.71%
Owned by Institutions (%)	4.93%
Float	2.75M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.64
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	33.50
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.64

Current Ratio	0.64
Quick Ratio	0.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-26.34

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-95.42%
Return on Invested Capital (ROIC)	-707.41%
Return on Capital Employed (ROCE)	-1,003.93%
Revenue Per Employee	$4,870
Profits Per Employee	-$684,783
Employee Count	23
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -94.25% in the last 52 weeks. The beta is 1.21, so AIM ImmunoTech's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	-94.25%
50-Day Moving Average	1.50
200-Day Moving Average	4.74
Relative Strength Index (RSI)	47.50
Average Volume (20 Days)	158,792

Short Selling Information

The latest short interest is 27,032, so 0.95% of the outstanding shares have been sold short.

Short Interest	27,032
Short Previous Month	6,913
Short % of Shares Out	0.95%
Short % of Float	0.98%
Short Ratio (days to cover)	0.47

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $112,000 and -$15.75 million in losses. Loss per share was -$14.89.

Revenue	112,000
Gross Profit	17,000
Operating Income	-14.57M
Pretax Income	-15.75M
Net Income	-15.75M
EBITDA	-14.34M
EBIT	-14.57M
Loss Per Share	-$14.89

Balance Sheet

The company has $2.41 million in cash and $2.34 million in debt, with a net cash position of $71,000 or $0.02 per share.

Cash & Cash Equivalents	2.41M
Total Debt	2.34M
Net Cash	71,000
Net Cash Per Share	$0.02
Equity (Book Value)	-6.08M
Book Value Per Share	-2.20
Working Capital	-1.47M

Cash Flow

Operating Cash Flow	-12.93M
Capital Expenditures	n/a
Free Cash Flow	-12.93M
FCF Per Share	-$4.53

Margins

Gross Margin	15.18%
Operating Margin	-13,006.25%
Pretax Margin	-14,062.50%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-102.28%
Shareholder Yield	-102.28%
Earnings Yield	-411.96%
FCF Yield	-338.10%

Analyst Forecast

The average price target for AIM ImmunoTech is $22.00, which is 1,541.79% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.00
Price Target Difference	1,541.79%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	129.07%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 12, 2025. It was a reverse split with a ratio of 1:100.

Last Split Date	Jun 12, 2025
Split Type	Reverse
Split Ratio	1:100

Scores

AIM ImmunoTech has an Altman Z-Score of -119.82 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-119.82
Piotroski F-Score	2